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OBJECTIVES The goal of this study was to define the association between low QRS voltage and cardiac
tamponade or pericardial effusion and to assess the reversibility of low QRS voltage after
therapeutic procedures.
BACKGROUND It is unclear whether low QRS voltage is a sign of cardiac tamponade or whether it is a sign
of pericardial effusion per se.
METHODS In a prospective study design, we recorded consecutive 12-lead electrocardiograms and
echocardiograms in 43 patients who were referred to our institution for evaluation and
therapy of a significant pericardial effusion. Cardiac tamponade was present in 23 patients
(53%). Low QRS voltage (defined as maximum QRS amplitude ,0.5 mV in the limb leads)
was found in 14 of these 23 subjects (61%). Nine of these 14 patients were treated by
pericardiocentesis (group A). Five patients received anti-inflammatory medication (group B).
Group C consisted of nine patients with pericarditis and significant pericardial effusion who
had no clinical evidence of tamponade.
RESULTS In group A, low QRS voltage remained largely unchanged immediately after successful
pericardiocentesis (0.36 6 0.17 mV before vs. 0.42 6 0.21 mV after, p 5 NS), but QRS
amplitude recovered within a week (0.78 6 0.33 mV, p , 0.001). In group B, the maximum
QRS amplitude increased from 0.40 6 0.20 mV to 0.80 6 0.36 mV (p , 0.001) within six
days. In group C, all patients had a normal QRS amplitude initially (1.09 6 0.55 mV) and
during a seven-day follow-up (1.10 6 0.56 mV, p 5 NS).
CONCLUSIONS Low QRS voltage is a feature of cardiac tamponade but not of pericardial effusion per se. Our
findings indicate that the presence and severity of cardiac tamponade, in addition to
inflammatory mechanisms, may contribute to the development of low QRS voltage in
patients with large pericardial effusions. (J Am Coll Cardiol 2001;38:219–26) © 2001 by the
American College of Cardiology
Cardiac tamponade and pericardial effusion have long been
associated with low voltage of the 12-lead electrocardiogram
(ECG) (1,2), and the diagnostic accuracy, sensitivity and
specificity of this ECG finding have previously been re-
ported (3,4). However, the question of whether low QRS
voltage is a sign of cardiac tamponade or of pericardial
effusion, per se, has not been specifically addressed. Various
animal models have been used to study electrocardiographic
features during intrapericardial fluid injection (5–7). How-
ever, in these experimental approaches, the authors focused
on the impact of acute cardiac tamponade, whereas gradual
intrapericardial fluid accumulation without tamponade was
not examined.
Different mechanisms have been proposed to explain low
QRS voltage associated with pericardial effusion and cardiac
tamponade. These mechanisms include mechanicoelectrical
alterations of the myocardium, distance of the heart from
body surface electrodes and reduction of cardiac size and
volume (5–7). However, the influence of different therapeu-
tic interventions such as pericardiocentesis or anti-
inflammatory drug treatment on reduced QRS voltage has
not been elucidated. This investigation was designed to
clarify the association between low QRS voltage and cardiac
tamponade or pericardial effusion and to assess the revers-
ibility of low QRS voltage after different therapeutic inter-
ventions.
METHODS
In a prospective design, consecutive 12-lead ECGs and
echocardiograms were recorded in 43 hospitalized patients
(age 56 6 18 years, 27 men/16 women) who were referred
to our institution (University Clinic Essen) for evaluation
and management of a significant pericardial effusion (vol-
ume of the effusion .300 ml, mean 460 ml 6 180 ml).
Patients were referred from a variety of medical and surgical
services, including cardiothoracic surgery. The causes of the
effusion were previous cardiothoracic surgery (n 5 19),
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cancer (n 5 13), heart failure (n 5 3), tuberculosis (n 5 1),
renal failure (n 5 3), postmyocardial infarction (n 5 1) and
idiopathic (n 5 3).
Clinical features of cardiac tamponade were present in 23
of these 43 patients (53%). Signs and symptoms included
right ventricular compression (n 5 19), right atrial com-
pression (n 5 12), dyspnea at rest (n 5 17), neck vein
distension (n 5 10) and inferior vena cava plethora (n 5 9),
indicating the need for therapy in all patients.
Low QRS voltage (defined as maximum QRS amplitude
,0.5 mV in the limb leads, mean 0.39 mV 6 0.22 mV) was
observed in 14 of 23 subjects with cardiac tamponade (61%).
Nine of these 14 patients (seven men, two women, age 51 6
14 years, group A) were treated by pericardiocentesis guided
by two-dimensional echocardiography (8). In five patients
(two men/three women, 48 6 18 years, group B), anti-
inflammatory medication was started (duration 4 to 21 days,
mean 7 6 7 days). Medical treatment was chosen due to
Dressler syndrome (n 5 2), severe thrombocytopenia (n 5
1), oral anticoagulation (n 5 1) or recurrent effusion (n 5
1). In this group, two patients had a history of gastrointes-
tinal ulcer disease. Treatment was performed either with
prednisolone in tapering dosage starting with 500 mg (n 5
1) or 100 mg (n 5 1) or nonsteroidal anti-inflammatory
agents (diclofenac 3 3 50 mg/day [n 5 2], indomethacine
50 mg/day [n 5 1]). Group C consisted of nine patients (six
men/three women, age 42 years 6 18 years) with pericar-
ditis and significant pericardial effusion (mean volume
472 ml 6 272 ml) but no clinical evidence of tamponade.
In all study subjects, a baseline 12-lead ECG was
recorded. In group A, all patients received consecutive ECG
recordings for one week after pericardiocentesis. In group B,
a second ECG was obtained 6 days 6 3 days after initiation
of anti-inflammatory drug treatment. In group C, a second
ECG was obtained after 7 days 6 2 days during follow-up.
In all patients, the volume of the pericardial effusion was
quantified by two-dimensional echocardiography every 48
or 72 h.
12-lead ECG. An electrocardiograph (Marquette, Hellige;
Freiburg, Germany) was used to record all 12-lead ECGs.
Paper speed was 50 mm/s, and standardization was 10
mV/10 mm. Each ECG was independently reviewed by an
experienced cardiologist who had no knowledge of the
patients’ clinical history or echocardiographic results.
Echocardiography. Images were recorded with patients in
the left lateral decubitus position with a 3.75-MHz sector
probe using a Toshiba SSA 380 A Power Vision or a
Hewlett Packard Sonos 1500 machine (both commercially
available). The echocardiographic examination was done
using standard views and techniques according to the
guidelines of the American Society of Echocardiography
(9). The volume of the pericardial effusion was quantified as
previously described by Horowitz and co-workers (10).
Statistics. Data are expressed as mean value 6 SD. Vari-
ables derived from echocardiography and ECG analysis
were compared between the distinct groups using one-way
analysis of variance (ANOVA) and post-hoc Bonferroni
analysis. For variables with a non-normal distribution, a
one-way ANOVA on ranks was employed. A difference was
considered significant at p ,0.05.
RESULTS
Clinical data and baseline echocardiographic findings.
Patient demographics are given in Table 1. No differences
between the three study groups were observed with respect
to heart rate, left ventricular (LV) diameter and LV volume
indexes, interventricular septum and posterior wall thickness
and LV muscle mass index. The systolic blood pressure was
reduced in group A and group B. Left ventricular ejection
fraction was lower in group A patients than it was in group
B and C patients.
Volume measurements. In group A, the pericardial effu-
sion was successfully drained by pericardiocentesis in all
patients (572 ml 6 245 ml vs. 55 ml 6 32 ml, p , 0.001).
None of the patients had a recurrent effusion at a six-day
follow-up (55 ml 6 32 ml vs. 64 ml 6 38 ml, p 5 NS). In
group B, the volume of the effusion significantly decreased
from 461 ml 6 184 ml to 141 ml 6 82 ml (p , 0.001) at
day 6 after initiation of anti-inflammatory drug treatment.
In group C, the volume of the pericardial effusion did not
change significantly during a seven-day follow-up (472 ml 6
272 ml vs. 390 ml 6 233 ml, p 5 0.06). At the baseline
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram
LV 5 left ventricle or left ventricular
Table 1. Clinical Data
Group A
(n 5 9)
Group B
(n 5 5)
Group C
(n 5 9)
Age (yr) 51 6 14 46 6 16 42 6 18†
Gender, M/F 7/2 2/3 6/3
BSA (m2) 1.99 6 0.30 1.90 6 0.48 1.93 6 0.45
Heart rate (beats/min) 94 6 15 92 6 16 88 6 24
LVDDI (cm/m2) 2.3 6 0.3 2.4 6 0.4 2.5 6 0.4
LVSDI (cm/m2) 1.4 6 0.4 1.5 6 0.5 1.6 6 0.4
IVS (cm) 1.0 6 0.4 1.2 6 0.4 1.1 6 0.4
PW (cm) 1.0 6 0.3 1.0 6 0.2 1.1 6 0.3
LVMMI (g/m2) 124 6 37 141 6 47 142 6 60
LVEDVI (ml/m2) 56 6 18 55 6 22 54 6 12
LVESVI (ml/m2) 28 6 11 25 6 14 25 6 8
SVI (ml/m2) 28 6 18 30 6 13 29 6 11
SBP (mm Hg) 114 6 24 112 6 31 134 6 26*
DBP (mm Hg) 78 6 10 75 6 18 82 6 16
EF (%) 46 6 9* 54 6 9 55 6 8
*p , 0.05 compared with each of the other groups; †p , 0.05 compared with group A.
BSA 5 body surface area; DBP 5 diastolic blood pressure; EF 5 ejection fraction;
IVS 5 thickness of the interventricular septum; LVDDI 5 left ventricular diastolic
diameter index; LVEDVI 5 left ventricular end-diastolic volume index; LVESVI 5
left ventricular end-systolic volume index; LVMMI 5 left ventricular muscle mass
index; LVSDI 5 left ventricular systolic diameter index; PW 5 thickness of the
posterior wall; SBP 5 systolic blood pressure; SVI 5 left ventricular stroke volume
index.
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echocardiographic examination, the volume of the effusion
was smaller in groups B and C than in group A (p , 0.05,
respectively). At follow-up, a larger volume of the pericar-
dial effusion remained in group C patients in comparison
with groups A and B (p , 0.01, respectively).
ECG signs. In group A, the maximum QRS voltage in the
limb leads remained nearly unchanged immediately after
pericardiocentesis but consecutively increased within six
days (Fig. 1A). In group B, maximum QRS amplitude
significantly increased six days after initiation of anti-
inflammatory treatment (Fig. 1B). In group C, the baseline
ECG showed a normal maximum QRS amplitude in all
patients, which remained nearly unchanged during
follow-up (Fig. 1C).
At the baseline examination, comparison between groups
showed a significant reduction of the QRS amplitude in
groups A and B in comparison with group C (0.36 mV 6
0.17 mV and 0.40 mV 6 0.20 mV vs. 1.09 mV 6 0.55 mV,
p , 0.001, respectively). The difference between group A
and group B was not statistically significant. The maximum
QRS amplitude after anti-inflammatory therapy was signif-
icantly higher in group B patients than in group A patients
immediately and three days after pericardiocentesis
(0.82 mV 6 0.37 mV vs. 0.42 mV 6 0.21 mV, p , 0.001
and 0.82 mV 6 0.37 mV vs. 0.56 mV 6 0.26 mV, p , 0.01,
respectively). Six days after initiation of therapy, no signif-
icant difference in QRS amplitude was detected between
groups A and B (0.78 6 0.33 vs. 0.82 6 0.37, p 5 NS). At
this time, QRS amplitude remained significantly decreased
in groups A and B in comparison with group C (0.78 6
0.33 and 0.82 6 0.37 vs. 1.10 6 0.56, p , 0.05, respec-
tively).
Representative examples of groups A and B with simul-
taneous ECG and echocardiography recordings before and
after treatment are shown in Figure 2A to C and Figure 3A
and B.
DISCUSSION
In the current investigation, we report for the first time
serial, simultaneous ECG and echocardiographic recordings
in patients with large pericardial effusions. The main finding
is that low QRS voltage was present in the majority of
subjects with cardiac tamponade but not in patients with
pericarditis and large pericardial effusions who were clini-
cally stable. Low QRS voltage persisted immediately after
successful pericardiocentesis, but QRS amplitude recovered
within one week (Fig. 1A, Fig. 2A to C). During successful
Figure 1. (A) Maximum QRS amplitude in the limb leads in group A patients, who where treated with pericardiocentesis. AP 5 immediately after
pericardiocentesis; BP 5 before pericardiocentesis; d3 5 three days after pericardiocentesis; d6 5 six days after pericardiocentesis. (B) Maximum QRS
amplitude in the limb leads in group B patients, who were treated with anti-inflammatory medication. BT 5 before anti-inflammatory treatment; d6 5
six days after initiation of anti-inflammatory medication. (C) Maximum QRS amplitude in the limb leads in group C patients (pericarditis). d0 5 baseline
measurement; d7 5 after a seven-day follow-up.
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Figure 2. (A) Simultaneous echocardiography (left side of the panel, apical four-chamber view) and electrocardiogram recordings (right side of the panel)
in a 64-year-old man who developed significant pericardial effusion (PE) with signs of cardiac tamponade three weeks after mitral valve replacement. Note
the reduction of the QRS amplitude in the limb leads and concomitant nonspecific T wave abnormalities. (B) Same patient as in (A) after successful
pericardiocentesis with removal of 600 ml of pericardial fluid. Note the even lower QRS voltage in the limb leads than before pericardiocentesis and the
persistence of nonspecific T wave abnormalities. Figure 2 continued on next page.
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anti-inflammatory treatment, low QRS voltage disappeared
within six days (Fig. 1B and Fig. 3A and B). In patients
with pericarditis who had a normal QRS amplitude, no
change in the QRS amplitude was observed during
follow-up (Fig. 1C).
Mechanism of low QRS voltage in pericardial effusion.
Several mechanisms have been proposed to explain the
association between pericardial effusion and low QRS volt-
age, namely internal short circuiting of the electrical cur-
rents by the accumulated fluid within the pericardial space
(6), change in the position of the heart (6), increasing
distance from the current generator to the recording elec-
trodes (5,11), decrease in cardiac chamber size and volume
(7,12) and changes in the generation and propagation of
electrical currents in the myocardium (7). However, only a
few investigators have tried to clarify the mechanisms of low
QRS voltage with pericardial effusion in an experimental
approach (7,11,13).
Karatay and co-workers (7) produced cardiac tamponade
in closed-chest pigs by the introduction of saline, blood and
plasma into the pericardial space (7). As a consequence,
mean limb and precordial lead QRS voltage fell signifi-
cantly, with no significant difference among these fluids.
Electrocardiographic recordings from a unipolar electrode
catheter in the right ventricle showed an increase in R wave
voltage, whereas body surface recordings of stimuli intro-
duced into the right atrium via a bipolar electrode catheter
showed no amplitude change. The authors of this study
attributed their results to a reduction of cardiac volume and
size during cardiac tamponade. In their view, the results
confirmed Brody’s hypothesis, which claims that alterations
in end-diastolic blood volume will change the magnitude of
cardiac electrical potentials recorded at the body surface
(12).
In an earlier experiment, Friedman and co-workers (13)
studied the electrocardiographic features of experimental
cardiac tamponade in closed-chest dogs. In their study,
acute cardiac tamponade produced by rapid saline infusion
into the pericardium induced reduction of the QRS ampli-
tude and left-axis deviation of the QRS complex, whereas
the amplitude of the P wave remained essentially un-
changed. Interestingly, in agreement with the findings of
Karatay and co-workers, the amplitude of bipolar ventricu-
lar ECG increased during tamponade, further supporting
Brody’s concepts. However, the authors of these animal
studies focused on the impact of a rapidly produced cardiac
tamponade but not on a gradual intrapericardial fluid
accumulation, which more closely reflects the situation in a
daily clinical setting.
The findings obtained in our study suggest that different
mechanisms may interplay to explain low QRS voltage in
patients with pericardial effusion and cardiac tamponade.
Figure 2. Continued from previous page. (C) Same patient six days after pericardiocentesis. The echocardiogram shows no evidence of recurrent effusion.
QRS amplitude in the limb leads significantly increased. LV 5 left ventricle; RV 5 right ventricle.
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Figure 3. (A) A 23-year-old man with acute lymphatic leukemia who was treated with prednisolone due to recurrent malignant pericardial effusion. Note
low QRS voltage in the limb leads before initiation of medical treatment. (B) Same patient as in (A) six days after initiation of anti-inflammatory treatment.
Note the change of the QRS axis and the significant increase of maximum QRS amplitude in the limb leads. LV 5 left ventricle; RV 5 right ventricle.
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The presence and severity of cardiac tamponade seem to be
crucial factors because low QRS amplitude was observed
only in subjects with clinical evidence of tamponade but not
in patients with pericarditis and large effusions who were
clinically stable. However, in patients with cardiac tampon-
ade, no changes in the maximum QRS amplitude were
observed immediately after pericardiocentesis. Following
Brody’s hypothesis, successful removal of intrapericardial
fluid during pericardiocentesis should have increased the
end-diastolic blood volume. Thus, the QRS amplitude
should have increased after the procedure.
Other mechanisms that may contribute to the develop-
ment of low QRS voltage include inflammation as well as
changes in the propagation and generation of electrical
currents in the myocardium. Previously, it has been dem-
onstrated that the epicardial circumference shortens propor-
tionally less than the endocardial circumference, resulting in
different tension distributions (14). Schlant and Hurst (15)
have shown the strong impact of these electrical inhomo-
geneities on the surface ECG. Friedman and co-workers
(13) have demonstrated that both intrapericardial and end-
diastolic intraventricular pressures rise during cardiac tam-
ponade, leading to compression of the myocardium in
between. This increase of end-diastolic ventricular pressure
contributes to the approximation of the surfaces of the
myocardium. As a consequence, the mechanicoelectrical
conditions of the endocardial and the epicardial myocar-
dium become more alike, offering an explanation for the
changes present in the surface ECG (7). However, in our
study, QRS amplitude normalized six days after initiation of
anti-inflammatory treatment, also suggesting a potential
role of inflammation.
Low QRS voltage in the management of patients with
pericardial effusion. The diagnostic value of low QRS
voltage for the diagnosis of pericardial effusion and cardiac
tamponade has previously been reported (1,2,4). Eisenberg
and co-workers (4) studied ECGs in 107 patients with small
effusions, in 29 patients with large and moderate effusions
and in 12 patients with cardiac tamponade. They found a
mild association of low QRS voltage with large and mod-
erate effusions (odds ratio 5 2.5, 95% confidence interval
[CI]: 0.9 to 6.5, p 5 0.06) and a moderate association with
cardiac tamponade (odds ratio 4.7; 95% CI: 1.1 to 21.1, p 5
0.004). In this study, low QRS voltage was only suggestive,
but not diagnostic, of cardiac tamponade (4). These findings
are in agreement with our observations. In our study
population, low QRS voltage was present in 14 of 23
subjects with clinical evidence of tamponade but not in
subjects with pericarditis and large effusions. As a conse-
quence, although low QRS voltage is indicative of cardiac
tamponade, its absence does not rule out tamponade.
Other investigators studied ECG changes during
follow-up in patients with confirmed pericardial effusion or
cardiac tamponade. Unverferth and colleagues (16) reported
that, in 22 patients after pericardiocentesis, frontal-plane
and precordial voltages increased only slightly. In our study,
we also observed no significant change of the maximum
QRS amplitude immediately or in the first two days after
successful pericardiocentesis. Echocardiographic follow-up
in our study indicated that this persistent low QRS voltage
should not be mistaken as a sign of recurrent effusion in the
first days after pericardiocentesis. However, in this study
population, QRS amplitude had significantly increased
within six days from pericardiocentesis. Thus, in patients
who had already shown an increase of the QRS amplitude,
another decrease might indicate recurrent pericardial effu-
sion, but this remains speculative.
Study limitations. Several limitations of our study should
be noted. First, only patients with large pericardial effusions
(.300 ml) were included. Because the first ECG was
obtained simultaneously with the first echocardiogram, it
cannot be excluded that some patients had pre-existing low
QRS voltage. Second, no attempt was made to differentiate
between patients with acute and chronic pericardial effusion.
Accordingly, results of a cytological and chemical analysis of
the pericardial fluid were not considered. Third, no attempt
was made to measure intrapericardial or central venous
pressures at the time of pericardiocentesis. Such measure-
ments might have added valuable information with respect
to the ECG changes observed in subjects with cardiac
tamponade. Finally, our study group was small, and the
results should be confirmed in a larger patient population.
Conclusions. Low QRS voltage is observed in the majority
of subjects with cardiac tamponade but not in patients with
pericarditis and large pericardial effusions. After pericardiocen-
tesis and after initiation of anti-inflammatory treatment, QRS
amplitude normalizes within one week. Our findings suggest
that the presence and severity of cardiac tamponade, but also
inflammatory mechanisms, may contribute to the development
of low QRS voltage in patients with pericardial effusion.
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